Healthcare Sector

MRNA

Market Tracker

$45.65
+0.28
(+0.62%)
5:20 pm
Next Earnings: (est.) 11/05/22 12:00 am
  • MRNA (Selected)

    Moderna, Inc.

MRNA Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

MRNA Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRNA Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRNA Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

MRNA Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRNA Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
05/01/2026 CALL $55.00 10,995 +10,093 +1,118.96%
05/15/2026 PUT $37.00 4,379 +3,115 +246.44%
09/18/2026 CALL $50.00 2,803 +1,977 +239.35%
05/15/2026 CALL $50.00 25,916 +1,915 +7.98%
05/01/2026 PUT $30.00 1,686 +1,682 +42,050.00%
05/01/2026 PUT $39.00 1,576 +1,523 +2,873.58%
05/01/2026 CALL $60.00 916 -104 -10.20%
06/18/2026 PUT $22.50 2,301 -124 -5.11%
05/15/2026 CALL $26.00 451 -136 -23.17%
05/15/2026 PUT $30.00 1,655 -316 -16.03%
06/18/2026 CALL $50.00 1,996 -565 -22.06%
06/18/2026 PUT $20.00 10,535 -2,196 -17.25%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

MRNA Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.50% 9.96M 1.37B
Vanguard International Growth Fund 2.49% 9.9M 1.36B
Vanguard 500 Index Fund 1.93% 7.66M 1.05B
Invesco ETF Tr-Invesco NASDAQ 100 ETF 1.47% 5.83M 803.49M
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 1.45% 5.78M 796.35M
SPDR S&P 500 ETF Trust 0.93% 3.71M 511.13M
Fidelity 500 Index Fund 0.92% 3.67M 505.99M
iShares Core S&P 500 ETF 0.77% 3.06M 420.95M
Vanguard U.S. Growth Fund 0.74% 2.93M 403.55M
Select Sector SPDR Fund-Health Care 0.70% 2.77M 382.16M
Vanguard Growth Index Fund 0.69% 2.73M 375.5M
iShares NASDAQ Biotechnology ETF 0.68% 2.72M 374.27M
Vanguard Institutional Index Fund-Institutional Index Fund 0.64% 2.56M 353.12M
Vanguard Specialized-Health Care Fund 0.57% 2.25M 309.92M
Price (T.Rowe) Health Sciences Fund 0.30% 1.19M 163.53M
Growth Fund Of America Inc 0.28% 1.12M 154.54M
American Funds Insurance Ser-Growth Fund 0.19% 750k 103.31M
Fidelity Growth Company Fund 0.17% 668.97k 92.14M
Schwab Capital Trust-Schwab S&P 500 Index Fund 0.16% 639.04k 88.02M

MRNA News

  • Will S&P 500 Open Up Or Down On May 1 After Best Month Since 2020?

    05/01 04:50 am

    Benzinga

    Read more
  • Which Is the Better iShares ETF for Small-Cap Value Investing, ISCV or IWN?

    04/27 09:30 am

    The Motley Fool

    Read more
  • 3 Healthcare Stocks With the Most Durable Competitive Moats

    04/23 04:05 am

    The Motley Fool

    Read more
  • Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

    04/18 06:00 am

    GlobeNewswire Inc.

    Read more
  • Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe

    04/18 06:00 am

    GlobeNewswire Inc.

    Read more
  • PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma

    04/17 03:00 pm

    GlobeNewswire Inc.

    Read more
  • Looks Like M&A Week in 3 Different Sectors

    04/08 12:02 pm

    The Motley Fool

    Read more
  • Oil Tumbles, Nasdaq 100 Jumps 3% As Iran Says It's Ready To Halt Hostilities: 10 Stocks Moving

    03/31 02:09 pm

    Benzinga

    Read more
  • Moderna Stock is Soaring. Is It Too Late to Buy?

    03/25 03:10 pm

    The Motley Fool

    Read more
  • Pfizer vs Moderna: Which Pharma Stock Has More Upside?

    03/19 03:30 pm

    The Motley Fool

    Read more
  • CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

    03/17 10:46 pm

    GlobeNewswire Inc.

    Read more
  • ISCV vs. VBR: Which Small Cap Value Approach is Right for Investors?

    03/17 09:35 am

    The Motley Fool

    Read more
  • BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture

    03/10 08:40 am

    Benzinga

    Read more
  • 9 Biotech Stocks Trading Far Below Fair Value With Up to 250% Upside Potential

    03/05 03:42 pm

    Investing.com

    Read more
  • Moderna's Ups and Downs: Here's What You Need to Know Before Investing.

    02/25 09:15 am

    The Motley Fool

    Read more
  • Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?

    02/22 10:05 am

    Benzinga

    Read more
  • Billionaire Philippe Laffont Just Dumped CoreWeave and Opened a Position in a Stock That Soared Nearly 50% in January.

    02/21 06:10 am

    The Motley Fool

    Read more
  • Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot

    02/20 12:02 pm

    Benzinga

    Read more
  • 3 Once-in-a-Decade Buying Opportunities

    02/18 07:10 pm

    The Motley Fool

    Read more
  • Stock Market Today, Feb. 18: Nvidia Rallies As Meta Deal Boosts AI Confidence

    02/18 06:06 pm

    The Motley Fool

    Read more
  • FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars

    02/18 02:20 pm

    Benzinga

    Read more
  • Softer-Than-Expected Inflation Sparks Rally In These 10 Stocks

    02/13 11:01 am

    Benzinga

    Read more
  • 1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell

    02/10 02:15 pm

    The Motley Fool

    Read more
  • Moderna, Mexico Partner To Boost Local Vaccine Production

    02/10 01:26 pm

    Benzinga

    Read more
  • Should You Buy Moderna Before Feb. 13?

    02/10 12:15 am

    The Motley Fool

    Read more
  • Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

    02/05 04:57 am

    GlobeNewswire Inc.

    Read more
  • Tom Gardner's 2026 Outlook: Volatility, Government Scrutiny, and Two AI-Adjacent Stocks

    02/04 05:29 pm

    The Motley Fool

    Read more
  • CytomX Therapeutics to Present at Upcoming February Conferences

    02/04 09:00 am

    GlobeNewswire Inc.

    Read more
  • Stock Market Today, Jan. 20: ImmunityBio Soars Again After FDA Outlines Resubmission Path for ANKTIVA in Bladder Cancer

    01/26 06:02 pm

    The Motley Fool

    Read more
  • Hecla Mining, Moderna, And Micron Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio?

    01/25 10:01 am

    Benzinga

    Read more
  • Lipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies

    01/23 11:00 am

    GlobeNewswire Inc.

    Read more
  • Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Rise As BEA Pegs Q3 GDP At 4.4%— Microsoft, Moderna, Intel In Focus (UPDATED)

    01/22 09:46 am

    Benzinga

    Read more
  • Moderna Stock Rallies as Oncology Results Improve the Platform’s Value Case

    01/21 03:38 pm

    Investing.com

    Read more
  • Stocks Rebound On Trump's Remarks, Natural Gas Rockets: What's Moving Markets Wednesday?

    01/21 02:57 pm

    Benzinga

    Read more
  • Moderna Pops 17%—Is There Life in MRNA, Down 90% from COVID High?

    01/21 12:14 pm

    Investing.com

    Read more
  • Moderna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma

    01/20 05:21 pm

    Benzinga

    Read more
  • Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday?

    01/13 02:04 pm

    Benzinga

    Read more
  • My Top 5 Stocks to Buy in Early 2026

    01/07 05:15 am

    The Motley Fool

    Read more
  • Silver Jumps 6%, Platinum Up 8%, Palladium Up 11% As Metal Shock Erupts: What's Moving Markets Friday?

    12/26 01:47 pm

    Benzinga

    Read more
  • Nanobiotechnology Market to Hit USD 420.2 Billion by 2034, Fueled by 2025 Traffic Growth and Strategic Material & Product Innovations

    12/17 11:00 am

    GlobeNewswire Inc.

    Read more
  • XOMA Royalty Enters into Agreement to Acquire Generation Bio

    12/15 06:00 pm

    GlobeNewswire Inc.

    Read more
  • Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress

    12/11 08:00 am

    GlobeNewswire Inc.

    Read more
  • Seasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035

    12/03 11:00 am

    GlobeNewswire Inc.

    Read more
  • Where Will Vertex Pharmaceuticals Be in 5 Years

    11/27 07:31 am

    The Motley Fool

    Read more
  • AI Just Sparked Biotech's Biggest Rally Since 2004 — Why Isn't Anyone Talking About It?

    11/25 04:14 pm

    Benzinga

    Read more
  • CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

    11/13 09:00 am

    GlobeNewswire Inc.

    Read more
  • Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps

    11/12 08:00 am

    GlobeNewswire Inc.

    Read more
  • CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

    10/30 08:00 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: